Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort MedBot) filed its Monthly Return for the period ended 30 April 2026, detailing a sizeable conversion of Domestic Shares into H Shares.

Key Transaction • On 23 April 2026, 5.99 million Domestic Shares were re-designated as H Shares. • The move reduced outstanding Domestic Shares from 6.60 million to 0.61 million and lifted H-share count from 1.02 billion to 1.03 billion.

Post-conversion Share Profile • Issued H Shares: 1.03 billion (par value RMB 1 each). • Issued Domestic Shares: 0.61 million (par value RMB 1 each). • Total issued share capital remains unchanged at 1.03133 billion shares, but the proportion of H Shares rose to 99.94 %, further enhancing Hong Kong market liquidity.

Authorised / Registered Capital • H-share authorisation increased by RMB 5.99 million to RMB 1.03 billion, while Domestic Share authorisation fell by the same amount to RMB 0.61 million. • Aggregate authorised share capital stands at RMB 1.03133 billion.

Public Float Compliance MicroPort MedBot confirmed full compliance with the Main Board’s 25 % minimum public-float requirement following the conversion.

Other Capital Movements • No share options were exercised and no treasury shares were issued, repurchased, or cancelled during the month. • The company’s 2022 Share Option Scheme continues to allow up to 95.20 million new H Shares to be issued in future, though none were granted or exercised in April.

Governance and Regulatory Filings The company secretary confirmed that all regulatory conditions related to the share conversion were satisfied, and necessary filings have been completed.

The April share conversion consolidates MicroPort MedBot’s trading liquidity in Hong Kong without altering total capital, positioning the company for broader investor access through its expanded H-share base.